Diagnosing Dry Eye Disease

Cornea Sense is a Research to Business project, funded by Business Finland and Aalto University. We are transforming Dry Eye Disease (DED) diagnostics with patented technology for fast, non-invasive ocular surface hydration measurement.

For eye-care specialists

Reduced Time Per Patient - <1 minute per test with Cornea Sense vs. 5+ minutes for traditional methods, enabling more screenings and cost savings.

Simplified Process - One uniform metric for DED diagnosis; eliminates the need for multiple complex and time-consuming tests.

No Consumables Required - Non-invasive, pain-free, and non-contact testing eliminates recurring costs like cartridges or materials.
Enhanced Treatment Revenue - Early detection avoids severe outcomes like inflammation, corneal scarring, or ulcers, reducing risk of permanent damage.
Better Surgical Outcomes - Diagnosing DED pre-surgery (LASIK, cataracts) reduces risks of post-surgical complications and costs.

For patients

Prevent Disease Progression - Early detection avoids severe outcomes like inflammation, corneal scarring, or ulcers, reducing risk of permanent damage.

Reduced Treatment Costs - Early cases can use inexpensive treatments  instead of costly prescription medications or surgeries.

Improved Treatment Efficacy - Treatments are more effective when applied before significant ocular surface damage occurs.

We are supported by

Investors, do you want to talk to us?

We are gathering feedback from possible investors, use the infromation below to contact us.

Contacts

Address:
Cornea Sense R2B

Department of Electronics and Nanoengineering

Aalto University

Maarintie 8, 02150Espoo

Finland

Phone:
+358 50 470 7406
Email:
anton.chernenko (at) aalto.fi

Name *
Email *
Message *